Call for papers !                                                                                               

We are interested to hear from students, researchers and academics who have a particular interest in hive products and who would like to publish their research article in our new Journal of ApiProduct and ApiMedical Science.

Please read our Guidelines for authors (pdf) 

If you believe that you have a research article that would be of interest to us, please do not hesitate to send it to jaas@ibra.org.uk  or contact one of the editorial board.

Editorial Board

We are delighted to have the support and expertise of an international editorial board lead by Prof Rose Cooper (UWIC).

Please click here to view Editorial Board

How will papers be managed and how quickly will they be published?

Having submitted your paper you will recieve a reference number and will be kept informed of progress as it goes through the review process. As a purely electronic journal the JAAS editorial team intend to have the peer reviewed articles available on-line as quickly as possible. Please remember that the closer you follow our 'Instructions for authors' the quicker we will be able to publish!
 

Open Access Option

JAAS offers a discounted fee of £375.00 per article for the Open Access Option. This will be payable on acceptance. Authors will retain copyright of their article and will then be able to grant anybody the right to disseminate and reproduce it, provided that it is cited correctly and that no errors are introduced.
 

What is the scope of this journal?

JAAS will cover research on the six main hive products: honey, pollen, propolis, wax, royal jelly, and bee venom. It will publish research on the biologically relevant properties and substances of these products. Indeed, only the inclusion of such properties into standards can make their application in medicine successful. Unfortunately, advocates sometimes use hive products without a clear understanding of their effects or their precise mode of action.

To re-introduce different strategies into conventional medicine requires scientific data to demonstrate that improved outcomes will be established, because an evidenced-based approach was adopted during the 1990s. This journal aims to provide a forum where the efficacy and effectiveness of bee products with therapeutic properties can be presented, debated and evaluated using scientific principles.
 

Can IBRA guarantee quality articles?

The editorial team of renowned international specialists, will only allow the publication of scientific research of a high standard and within the scope of the journal.  Neither the management of IBRA, nor the editors are prepared to have the reputation of the journal or IBRA tainted by unfounded theories that may be linked to some of the more speculative applications of natural bee products.

Why produce yet another journal? 

Increasing publicity is given to hive products but at present much of this information lacks a sound basis in analytical science, and results that are published are spread throughout many journals. By providing the world with a single journal through which scientists can publish their peer reviewed findings on hive products, IBRA continues its mission of disseminating proven and practical information. 

Who should be reading this journal?

JAAS will target a larger and more diverse readership reflecting the growing interest and potential offered by the products of the hive.

IBRA aims to capture the attention of researchers in the pharmaceutical and food industries, the medical and veterinary sciences, as well as expanding upon its more traditional area of support, apiculture.